Evidence map›Paper›PMID 40427406›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Engeletin Targets Mitochondrial Dysfunction to Attenuate Oxidative Stress and Experimental Colitis in Intestinal Epithelial Cells Through AMPK/SIRT1/PGC-1α Signaling.

Jing Li, Zhijun Geng, Lixia Yin, Ju Huang, Minzhu Niu, Keni Zhang, Xue Song, Yueyue Wang, Lugen Zuo, Jianguo Hu

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Marine Collagen Peptide Fraction fromFoods (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Sappanone A Promotes Motor Function Recovery in Spinal Cord Injury Mice by Inhibiting Microglial M1 Polarization via Activation of the Keap1/Nrf2 Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing LiDepartment of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.ORCID 0000-0002-1690-9548
Zhijun GengAnhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu 233004, China.ORCID 0000-0002-4040-5622
Lixia YinDepartment of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.ORCID 0009-0005-6852-5713
Ju HuangAnhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu 233004, China.ORCID 0009-0003-9758-4785
Minzhu NiuAnhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu 233004, China.ORCID 0009-0005-2581-3360
Keni ZhangDepartment of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.ORCID 0009-0000-3362-4651
Xue SongAnhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu 233004, China.ORCID 0000-0002-9610-030X
Yueyue WangDepartment of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.ORCID 0009-0007-6829-1050
Lugen ZuoAnhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu 233004, China.ORCID 0009-0006-9979-6062
Jianguo HuDepartment of Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.ORCID 0000-0003-0207-9536

Funding

Anhui Province University Outstanding Youth Research Project 2022AH030138Bengbu Medical University Research Projects 2023byfy002Clinical and Translational Research Project of Anhui Province 202427b10020088Health Research Program of Anhui AHWJ2022b088, 2024Aa40007National Natural Science Foundation of China 81902078, 82370534Outstanding Young Teachers Incubation Programme of Education Department of Anhui Province YQYB2023019Research and Innovation Program of Bengbu Medical University 2024xscx133the Research and Innovation Team of Bengbu Medical University BYYFY2022TD002
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is characterized by chronic intestinal inflammation and epithelial barrier disruption. Emerging evidence highlights mitochondrial dysfunction as a pivotal contributor to IBD pathogenesis, where impaired mitochondrial homeostasis in intestinal epithelial cells (IECs) disrupts redox balance, exacerbates oxidative stress, and triggers apoptosis, further compromising barrier integrity. This study investigated the therapeutic effects of Engeletin (Eng), a dihydroflavonoid from

Indexed as

antioxidantengeletininflammatory bowel diseaseintestinal barrierintestinal epithelial cells apoptosismitochondrial function

Identifiers

PMID40427406
PMCPMC12108241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.